Lightrock Netherlands B.V. Cuts Position in Avantor, Inc. $AVTR

Lightrock Netherlands B.V. reduced its stake in Avantor, Inc. (NYSE:AVTR) by 51.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 267,468 shares of the company’s stock after selling 287,912 shares during the period. Lightrock Netherlands B.V.’s holdings in Avantor were worth $3,065,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the stock. TD Private Client Wealth LLC increased its stake in Avantor by 9.2% in the third quarter. TD Private Client Wealth LLC now owns 7,985 shares of the company’s stock valued at $100,000 after purchasing an additional 670 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Avantor by 28.1% in the third quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,123 shares of the company’s stock valued at $49,000 after purchasing an additional 905 shares during the last quarter. TD Waterhouse Canada Inc. increased its stake in Avantor by 2.5% in the third quarter. TD Waterhouse Canada Inc. now owns 38,977 shares of the company’s stock valued at $532,000 after purchasing an additional 966 shares during the last quarter. Evergreen Capital Management LLC increased its stake in Avantor by 7.7% in the third quarter. Evergreen Capital Management LLC now owns 14,347 shares of the company’s stock valued at $179,000 after purchasing an additional 1,026 shares during the last quarter. Finally, Osaic Holdings Inc. increased its stake in Avantor by 60.9% in the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock valued at $38,000 after purchasing an additional 1,064 shares during the last quarter. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Avantor Price Performance

AVTR stock opened at $8.35 on Thursday. The company has a market capitalization of $5.69 billion, a P/E ratio of -10.70, a PEG ratio of 3.22 and a beta of 1.00. Avantor, Inc. has a twelve month low of $7.26 and a twelve month high of $16.17. The business has a 50 day simple moving average of $8.53 and a 200-day simple moving average of $10.88. The company has a current ratio of 1.78, a quick ratio of 1.18 and a debt-to-equity ratio of 0.70.

Avantor (NYSE:AVTR) last posted its quarterly earnings data on Wednesday, February 11th. The company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.21 by $0.01. The business had revenue of $1.66 billion during the quarter, compared to the consensus estimate of $1.64 billion. Avantor had a positive return on equity of 10.45% and a negative net margin of 8.09%.The company’s revenue was down 1.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.27 earnings per share. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. As a group, equities analysts anticipate that Avantor, Inc. will post 1.06 EPS for the current year.

Insider Buying and Selling

In related news, Director Gregory T. Lucier purchased 50,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 19th. The stock was purchased at an average cost of $9.16 per share, with a total value of $458,000.00. Following the completion of the acquisition, the director directly owned 50,000 shares in the company, valued at $458,000. This trade represents a ? increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Gregory L. Summe purchased 100,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 12th. The shares were bought at an average cost of $9.40 per share, with a total value of $940,000.00. Following the completion of the acquisition, the director owned 400,000 shares of the company’s stock, valued at approximately $3,760,000. This trade represents a 33.33% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders purchased a total of 275,000 shares of company stock valued at $2,399,250 over the last three months. 0.28% of the stock is currently owned by company insiders.

Analyst Ratings Changes

AVTR has been the topic of several recent analyst reports. Wells Fargo & Company dropped their price target on shares of Avantor from $16.00 to $14.00 and set an “overweight” rating on the stock in a research note on Friday, February 13th. Citigroup dropped their price target on shares of Avantor from $13.00 to $11.00 and set a “neutral” rating on the stock in a research note on Thursday, February 12th. UBS Group reiterated a “neutral” rating and issued a $10.50 price target on shares of Avantor in a research note on Thursday, February 12th. Evercore set a $10.00 price target on shares of Avantor in a research note on Wednesday, February 11th. Finally, Jefferies Financial Group reissued an “underperform” rating and issued a $8.00 price objective on shares of Avantor in a report on Thursday, February 12th. Three investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $11.70.

About Avantor

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.